Semaglutide and kidney function: friends or enemies?

Semaglutide and kidney function: friends or enemies?

Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RAs) approved for the treatment of type 2 diabetes mellitus (T2DM) and chronic weight management in obesity. GLP-1RAs are being investigated to slow the decline of kidney function in type 2 diabetics with chronic kidney disease. These...

Full description

Bibliographic Details
Main Authors: Federica Giofrè, Vincenzo Trapanese, Maria Resilde Natale, Clara Vatalaro, Francesca Cosentino, Melania Melina, Maria Chiara Pelle, Nazareno Carullo, Maria Capria, Franco Arturi
Format: Article
Language:English
Published: PAGEPress Publications 2024-02-01
Series:Italian Journal of Medicine
Subjects:
Semaglutide
glucagon-like peptide-1 receptor agonist
type 2 diabetes
acute kidney injury
obesity
Online Access:https://italjmed.org/index.php/ijm/article/view/1694

Internet

https://italjmed.org/index.php/ijm/article/view/1694

Similar Items